| 000 | 01660 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515175824.0 | ||
| 264 | 0 | _c20091013 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2009.05.082 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYe, Yang-liang | |
| 245 | 0 | 0 |
_aDiscovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cAug 2009 |
||
| 300 |
_a5722-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a11-beta-Hydroxysteroid Dehydrogenase Type 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aFats _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aObesity _xchemically induced |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 |
_aPhenylpropionates _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aZhou, Zhou | |
| 700 | 1 | _aZou, Han-jun | |
| 700 | 1 | _aShen, Yu | |
| 700 | 1 | _aXu, Ti-Fei | |
| 700 | 1 | _aTang, Jing | |
| 700 | 1 | _aYin, Hua-zhong | |
| 700 | 1 | _aChen, Min-li | |
| 700 | 1 | _aLeng, Ying | |
| 700 | 1 | _aShen, Jian-hua | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 17 _gno. 15 _gp. 5722-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2009.05.082 _zAvailable from publisher's website |
| 999 |
_c18990161 _d18990161 |
||